CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT CNS PHARMACEUTICALS INC.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)
Listen to this Section


$5.03
-0.2490 ( -4.72% ) 3.9K

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Market Data


Open $5.03
Previous Close $5.28
Volume 3.9K
Market Cap $7.66M
Day Range $5.02 - $5.19
52 Week Range $1.90 - $12.84
Shares Outstanding 1.46M
Change % -4.72%
Net Change ▼ -0.2490
Insider Ownership N/A
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2019
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -249,041.00

Date Type Amount Purchased Purchaser
2023-08-23 Buy 27000.00 Downs Christopher
2023-08-16 Buy 2750.00 Climaco John M

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 42 Nov 14, 2025
schedule Other 1 Nov 14, 2025
defa14a Other 3 Nov 12, 2025
schedule Other 2 Nov 04, 2025
ars Annual reports 1 Oct 28, 2025
def Proxies and info statements 15 Oct 24, 2025
pre Proxies and info statements 15 Oct 10, 2025
10-q Quarterly Reports 42 Aug 14, 2025
8-k 8K-related 16 Jul 22, 2025
8-k 8K-related 33 Jul 15, 2025

Latest News


× Before browsing our site, please accept our cookies policy